Xcout Intel
Celea Therapeutics
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
Subscribe to see Celea Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Celea Therapeutics at a glance
Celea Therapeutics is a biotech company. Its most recent funding round, Seed, raised $180M in July 2026. Xcout tracks 4 named people at Celea Therapeutics, including Sven Dethlefs (Chief Executive Officer). Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days.
Celea Therapeutics leadership
- Sven DethlefsChief Executive Officer
- Camilla GrahamMedical Affairs
- David GolodClinical Operations & Program Strategy
- Neera JainChemistry, Manufacturing, and Controls
Celea Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $180M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Celea Therapeutics
Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Celea Therapeutics's hiring signals →
Investors
Tech stack
Celea Therapeutics competitors
A few of Celea Therapeutics's closest competitors — see the full list of competitors and alternatives →
Enalare Therapeutics Inc. is a privately held, clinical-stage biopharmaceutical company headquartered in Princeton, New Jersey, focused on developing novel therapies for acute respiratory and critical care conditions.
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Savara Inc. is a clinical-stage biopharmaceutical company founded in 2007 and focused on developing treatments for rare respiratory diseases.
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Alveolus Bio is a privately held drug development company and team of scientists, physicians, and innovators headquartered in Boston, Massachusetts, pioneering breakthrough FDA-approved therapeutics for lung diseases.
Get Celea Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Celea Therapeutics? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Celea Therapeutics in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access